Our Vascular Intervention division consists of a diverse portfolio of cleverly iterated products, with novel design and engineering principles. Used in over 100 countries, our product portfolio includes drug eluting stents, bioresorbable scaffolds, balloon catheters, and transcatheter aortic valve replacement systems (TAVR), along with a robust pipeline of products in continuous development.
All our Vascular Intervention medical devices are backed by clinical studies, conducted with a global patient base and supported by a team of scientific advisors from all over the world. We have complete control over the manufacture process of each of these products, with strong validation, leading to a completely integrated manufacture system.
Connect with Meril
Cardiac Surgery
